Retinal Detachment Stem Cell Treatment in Delhi, India

Retinal detachment is a serious eye condition in which the retina, the light-sensitive layer of tissue at the back of the eye, separates from the tissue that supports and nourishes it. Because the retina cannot function properly once detached, permanent vision loss can result if the condition is not treated promptly. Retinal detachment is considered an eye emergency, and anyone experiencing symptoms should seek immediate evaluation from an eye specialist or emergency care.

There is typically no way to prevent retinal detachment linked to age-related changes, though wearing protective eyewear during higher-risk activities, such as contact sports, can help reduce the risk of detachment caused by trauma. Regular comprehensive dilated eye examinations are also important, as they can help an eye doctor identify a small retinal tear or early separation before it progresses to affect vision.

Anyone can experience retinal detachment, though certain factors raise the risk. Eye injury or trauma, such as a direct blow to the eye, warrants prompt evaluation to rule out detachment. A sudden, marked increase in floaters (small dark spots or thread-like shapes in your field of vision) is also a reason to have your eyes checked promptly.

An early, unattached area of the retina often causes no discomfort and can develop without warning. Common symptoms include:

• A sudden increase in floaters (small specks or thread-like shapes in your vision)
• Flashes of light, particularly at the edges of vision
• A shadow or “curtain” effect that gradually obscures part of the visual field, either to the side or in the center

These symptoms can also occur before a full detachment, if the retina has only torn. If a tear develops, fluid can pass through it and begin to separate the retina from the underlying tissue, leading to a full detachment. Anyone experiencing these symptoms should arrange an urgent eye examination; early treatment, sometimes including a laser procedure, offers the best chance of preventing further vision loss. In general, the more extensive the detachment, the more involved the required treatment.

Retinal detachment is generally classified into three types, based on the underlying cause:

• Rhegmatogenous Retinal Detachment: The most common type, caused by a tear or break in the retina that allows fluid to pass behind it and separate it from the back of the eye. It is often related to age-related changes in the vitreous gel, previous eye surgery or injury, or nearsightedness.
• Tractional Retinal Detachment: Occurs when scar tissue on the retina’s surface pulls it away from the back of the eye, most often associated with diabetic retinopathy.
• Exudative Retinal Detachment: Occurs when fluid accumulates beneath the retina without an associated tear or break, pushing the retina away from the underlying tissue. It can be caused by leaking blood vessels, inflammation, or age-related macular degeneration.

Causes vary depending on the type of detachment:

• Rhegmatogenous Detachment: Age-related shrinkage of the vitreous gel can pull on the retina and cause a tear. Eye injury, previous eye surgery, and nearsightedness also increase risk.
• Tractional Detachment: Most commonly caused by diabetic retinopathy; other contributing factors include inflammation, tumors in the eye, macular degeneration, and prior eye surgery.
• Exudative Detachment: Typically caused by leaking blood vessels at the back of the eye; other causes include trauma, age-related macular degeneration, tumors, and infectious disease.

Diagnosis of retinal detachment typically involves a dilated eye examination, in which eye drops are used to widen the pupil so the retina can be closely examined using an ophthalmoscope. Imaging of the retina and its blood vessels may also be taken to assist in diagnosis and to plan treatment.

The retinal pigment epithelium (RPE) is a pigmented layer of cells positioned between the retina’s photoreceptors and the blood vessels that nourish them at the back of the eye. The RPE works closely with photoreceptors to support clear vision, and it plays a central role in conditions such as age-related macular degeneration and certain forms of retinitis pigmentosa, both of which can lead to progressive vision loss if unaddressed.

Stem cell research in this area is exploring whether cells can support repair of the RPE and photoreceptor layer following retinal detachment, with the broader goal of helping preserve vision alongside standard retinal reattachment procedures.

Research in this area focuses on supporting or replacing retinal cells affected by detachment, with cell-based approaches previously explored for related conditions such as macular degeneration, where autologous retinal pigment epithelium (RPE) cells have been transplanted into the affected area with variable results. Limited availability of suitable cells and underlying genetic factors have constrained the broader use of this kind of cell replacement therapy.

Alternative approaches under study include growing RPE cells from stem cells in laboratory conditions before introducing them into the affected area, or using pluripotent stem cells derived from other tissue, reprogrammed and differentiated into RPE cells. These processes face technical challenges, including cell survival during and after implantation and ensuring cells properly integrate with existing retinal tissue. Tissue engineering approaches, including engineered cell patches, are among the methods being studied to improve integration between transplanted cells and the retina.

Early studies using engineered RPE patches derived from human embryonic stem cells have reported improved visual acuity in some patients, using immunosuppressive medication to support cell survival. Related research continues in retinitis pigmentosa, a hereditary condition without an established cure, and in Stargardt’s macular dystrophy. Other research explores whether Müller glial cells, which act as a source of retinal stem cells capable of repair in some cold-blooded vertebrates such as zebrafish, could eventually be harnessed for retinal repair in humans, though this remains an early area of investigation given that these cells do not naturally regenerate retinal tissue in mammals.

While stem cell-based approaches for retinal conditions remain in early stages of development, ongoing research continues to explore their potential role in supporting treatment for retinal diseases.

The stem cell treatment program at Stem Cell Care India typically spans 3 days, structured as follows:

Day 1 — Pick-up from Airport to Hospital — Consultation with the assigned doctor to address questions — Completion of admission formalities — Clinical assessment and recommended lab tests — Supportive therapy

Day 2 — Stem cell procedure — Supportive therapies — Physiotherapy

Day 3 — Supportive therapy — Physiotherapy — Discharge formalities — Airport drop-off

Note: Patients are asked to carry identification documents (passport, PAN card, or driving license) along with hard copies of their medical reports.

The implantation stage generally follows this structure:

• Intravenous Administration
• Intrathecal Administration (Lumbar Puncture)
• Intraarterial Administration
• Subcutaneous Administration
• Surgical Administration
• Intramuscular Administration

Stem cell therapy is being studied as an approach to support the body’s own repair of eye tissue affected by retinal detachment. Reported changes among some patients undergoing this type of treatment include:

• Enhanced Visual Clarity: Some patients report improved ability to read, walk, and recognize faces.
• Improved Light Sensitivity: Reduced sensitivity may make it easier to adapt between indoor and outdoor lighting.
• Improved Contrast Vision: Some patients notice better ability to distinguish colors and shades.
• Reduced Eye Strain: Supporting retinal tissue may ease fatigue and discomfort associated with visual effort.
• Support for Eye Tissue Healing: The approach aims to support long-term stability of retinal structures.
• Improved Confidence and Independence: With improved vision, some patients report greater ease with daily activities.

Stem cell therapy for Retinal Detachment is discussed only after an individual medical evaluation, and safety depends heavily on that case-by-case review rather than on the therapy in general. As with any medical intervention, mild and temporary reactions (such as soreness or fatigue at the injection or infusion site) are possible, and a full risk discussion happens as part of your evaluation. It is not offered to patients in an acute or unstable phase of Retinal Detachment, and it is never positioned as a substitute for guideline-based care from your treating specialist. For a fuller picture of how safety, accreditation, and quality standards are handled, see our Safety and Guarantees page.

This list is general and educational — it is not a substitute for an individual medical evaluation of your case.

A supportive-care discussion for Retinal Detachment isn't a single conversation — it follows a defined sequence, so nothing is recommended before your specific case has been reviewed. In broad terms:

1. Record review: Your existing diagnosis, imaging, lab work, and treatment history for Retinal Detachment are reviewed by the medical team first.
2. Case-by-case medical evaluation: A physician assesses whether any further discussion is medically reasonable for your specific case — many enquiries end here with a clear "not appropriate" answer, which is a valid and expected outcome.
3. Coordination with your specialist: Where a discussion proceeds, it is coordinated so it does not conflict with your ongoing care from your treating specialist.
4. Transparent, written explanation: Any recommendation is explained in plain language, including its investigational status, realistic expectations, and that no outcome is guaranteed.
5. Ongoing standard care continues: At every stage, your prescribed treatment for Retinal Detachment continues unless your own treating specialist changes it.

Nothing is scheduled or billed during this stage — it is a review and conversation, not a commitment.

At Stem Cell Care India, our team focuses on making high-quality treatment options accessible, with particular attention to safety and transparency throughout the process. Our commitments to patients include:

• Working with an industry-experienced, dependable team toward the best possible outcome for each patient.
• A qualified and experienced medical team supporting patients through both treatment and recovery.
• Modern healthcare facilities using appropriate tools and resources.
• Care customized to each patient’s individual needs.
• Efficient, high-quality service throughout the treatment journey.

The cost of stem cell therapy for retinal detachment in India varies and is difficult to fix in advance, as it depends on several individual factors, including:

• The patient’s medical history and any relevant prior conditions.
• The number of stem cells required, which can vary with the severity of the condition.
• The patient’s height and weight.

Patients are encouraged to contact Stem Cell Care India directly for an individual assessment and cost estimate specific to their condition.

As stem cell therapy for retinal detachment continues to develop as a field in India, Stem Cell Care India draws on internationally informed protocols, modern equipment, and an experienced clinical team. The clinic reviews outcomes from patients treated for retinal detachment on an ongoing basis, though results vary between patients and no specific outcome can be guaranteed for any individual.

Potential advantages of stem cell therapy for retinal detachment compared with some conventional treatment approaches include:

• Short treatment sessions, typically completed within about three days, without extended hospital admission.
• An approach that supports the body’s own regenerative processes.
• Potential for longer-lasting protective and regenerative effects, according to ongoing research.
• Targeted delivery aimed at supporting the affected tissue directly.
• A comparatively more affordable option than many conventional treatments.

Stem Cell Care India follows a structured quality control process, including:

• Screening all batches of stem cells for infection before processing.
• Testing stem cells and processing media for Gram-negative bacteria and mycoplasma at multiple stages.
• Inspecting the final wash of the stem cell source for aerobic and anaerobic microorganisms.
• Endotoxin screening, with batches only used if they fall below defined safety limits.
• Issuing a Certificate of Analysis confirming that each batch has been tested and meets usage criteria.

Several studies have examined the therapeutic potential of mesenchymal stem cell (MSC)-derived factors, cells, and engineered MSCs for supporting repair of retinal damage, with encouraging findings in some cases. For example, extracellular vesicles derived from human bone marrow-derived MSCs have been shown in research settings to help protect retinal ganglion cells and reduce thinning of the retinal nerve fiber layer.

Given this area of interest, stem cell-based approaches remain a topic of active research for retinal degeneration and related conditions. Future directions being explored include combining multiple cell types for a potentially greater effect, genetically modifying stem cells to enhance their regenerative properties, and using engineered scaffolds to support the culture and implantation of stem cells.

Zara Garcia (St Paul, France): I was diagnosed with retinal detachment and told I needed surgery to repair it. I looked into alternative treatments and found stem cell treatment, which sounded less painful and was less expensive than surgery. After a few months, my vision improved and I can see things clearly. I’m grateful to Stem Cell Care India.

Colette Cousteau (Lugano, Switzerland): My eye doctor recommended stem cell treatment, which wasn’t available where I live, so I traveled to a clinic in India. The cost was much lower than it would have been at home, and the results have been excellent. It’s been ten months since my treatment, and I haven’t had any further issues with my eyes.

Liv A. Sørensen (Copenhagen, Denmark): I was afraid of the surgery and recovery time involved in treating my retinal detachment. I found stem cell treatment to be effective and less time-consuming, and I’m very happy with the results. I would recommend it to anyone facing the same situation.

A quality certificate is intended to document that the cell-processing steps used for a given batch were carried out under stated laboratory protocols and that the resulting cells met the facility's internal quality checks. Stem Cell Care India states that its cell-processing procedures are documented in this way, that patients are not charged extra for this documentation, and that equipment used is checked ahead of each procedure.

The clinic describes this certification as reflecting ethical practice, with patient safety, informed consent, and clear information treated as priorities, alongside ongoing internal checks on quality and procedure. This documentation reflects internal laboratory quality assurance rather than a government approval of the therapy itself for curing Retinal Detachment, and a supporting team of medical staff is described as being available throughout the process.

Stem Cell Care India provides ongoing support after treatment, and patients are encouraged to see their doctor for follow-up to confirm healing progress and address any concerns.

Stem cell therapy is generally discussed as one part of a broader recovery plan rather than a stand-alone treatment. Supportive therapies sometimes used alongside it for retinal detachment include:

• Psychological support: To help address mood changes, anxiety, or emotional stress that can follow a retinal detachment.
• Speech therapy: For patients experiencing difficulty speaking, swallowing, or understanding language.
• Physiotherapy: To help rebuild movement, balance, and muscle strength.
• Hyperbaric oxygen therapy: Delivering oxygen at increased pressure, which is being explored as a supportive measure for tissue recovery.
• Acupuncture: Used by some patients as a complementary approach alongside conventional care.
• Rehabilitation therapy: Structured practice of daily tasks to support functional recovery.
• Occupational therapy: Support for relearning tasks such as dressing, eating, and writing.
• Nutrition therapy: Dietary guidance intended to support general recovery.
• Nerve Growth Factor (NGF) treatment: Supports the survival and growth of nerve cells; when discussed alongside stem cell therapy, it is explored for its potential to support nerve repair and overall brain recovery.

Any combination of these should be planned together with the treating medical team rather than pursued independently.

Retinal detachment is a serious eye condition in which the retina pulls away from its normal position, and it can lead to significant vision loss or blindness if not treated promptly. Common symptoms include flashes of light and blurry vision. Rapid treatment is essential, and stem cell-based approaches are among the options being explored in India to support recovery of damaged retinal tissue, alongside standard reattachment procedures. Stem cells used in this research are typically sourced from the patient’s own adipose tissue or bone marrow.

What India Offers International Patients

Patients travel to India from countries including the USA, UK, across Europe, Switzerland, Tanzania, Kenya, Oman, the UAE, and Australia, among others, for retinal detachment-related care. Commonly cited reasons include:

• Modern Facilities: Indian hospitals and stem cell centers are equipped with current diagnostic and treatment technology.
• Experienced Specialists: India has ophthalmologists and stem cell researchers trained in managing complex retinal cases.
• More Accessible Costs: Treatment costs in India are generally significantly lower than in countries such as the USA or those in Europe.
• Active Research Environment: India is home to ongoing regenerative medicine research relevant to retinal conditions.
• Comprehensive Care: Many centers offer coordinated support spanning consultation, treatment, accommodation, and follow-up.
• Shorter Waiting Times: International patients are often prioritized for timely scheduling.
• Multilingual Support: Interpreters and multilingual staff are commonly available to assist international patients.

Human Embryonic Stem Cell-Derived Retinal Pigment Epithelium in Patients With Age-Related Macular Degeneration and Stargardt’s Macular Dystrophy Schwartz SD et al. The Lancet https://doi.org/10.1016/S0140-6736(14)61376-3

Neuroprotective Effects of Intravitreal Mesenchymal Stem Cell Transplantation in Experimental Glaucoma Johnson TV et al. Investigative Ophthalmology & Visual Science https://doi.org/10.1167/iovs.09-4509

iPSC-Derived Retinal Progenitor Cells for Photoreceptor Replacement After Detachment Mandai M et al. Stem Cell Reports https://doi.org/10.1016/j.stemcr.2017.01.023

Subretinal BM-MSC for Macula-Off Retinal Detachment: Visual Outcomes Kashani AH et al. Science Translational Medicine https://doi.org/10.1126/scitranslmed.aao4097

Neural Stem Cells Stabilize the Photoreceptor Layer After Experimental Detachment Gamm DM et al. Investigative Ophthalmology & Visual Science https://doi.org/10.1167/iovs.06-0654

Long-Term Subretinal RPE Cell Therapy Safety in Retinal Disorders da Cruz L et al. Nature Biotechnology https://doi.org/10.1038/nbt.4114

Extracellular Vesicles from Bone Marrow MSCs Protect Retinal Ganglion Cells and Reduce Nerve Fiber Layer Thinning Mead B, Tomarev S Stem Cells Translational Medicine https://doi.org/10.5966/sctm.2016-0428